Oncology Institute (TOI) Competitors $2.80 -0.12 (-4.11%) As of 05/9/2025 04:00 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock TOI vs. CDNA, FLGT, CSTL, FTRE, TALK, AUNA, CELC, EHAB, INNV, and PSNLShould you be buying Oncology Institute stock or one of its competitors? The main competitors of Oncology Institute include CareDx (CDNA), Fulgent Genetics (FLGT), Castle Biosciences (CSTL), Fortrea (FTRE), Talkspace (TALK), Auna (AUNA), Celcuity (CELC), Enhabit (EHAB), InnovAge (INNV), and Personalis (PSNL). These companies are all part of the "healthcare" industry. Oncology Institute vs. CareDx Fulgent Genetics Castle Biosciences Fortrea Talkspace Auna Celcuity Enhabit InnovAge Personalis Oncology Institute (NASDAQ:TOI) and CareDx (NASDAQ:CDNA) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their media sentiment, institutional ownership, community ranking, analyst recommendations, valuation, profitability, earnings, dividends and risk. Do institutionals & insiders hold more shares of TOI or CDNA? 36.9% of Oncology Institute shares are owned by institutional investors. 8.5% of Oncology Institute shares are owned by company insiders. Comparatively, 4.9% of CareDx shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth. Do analysts rate TOI or CDNA? CareDx has a consensus price target of $30.33, suggesting a potential upside of 96.71%. Given CareDx's stronger consensus rating and higher possible upside, analysts clearly believe CareDx is more favorable than Oncology Institute.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Oncology Institute 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00CareDx 0 Sell rating(s) 3 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.57 Does the MarketBeat Community prefer TOI or CDNA? CareDx received 440 more outperform votes than Oncology Institute when rated by MarketBeat users. However, 66.67% of users gave Oncology Institute an outperform vote while only 65.78% of users gave CareDx an outperform vote. CompanyUnderperformOutperformOncology InstituteOutperform Votes466.67% Underperform Votes233.33% CareDxOutperform Votes44465.78% Underperform Votes23134.22% Which has more risk & volatility, TOI or CDNA? Oncology Institute has a beta of 0.04, indicating that its share price is 96% less volatile than the S&P 500. Comparatively, CareDx has a beta of 2.27, indicating that its share price is 127% more volatile than the S&P 500. Is TOI or CDNA more profitable? Oncology Institute has a net margin of -17.63% compared to CareDx's net margin of -45.90%. CareDx's return on equity of -53.70% beat Oncology Institute's return on equity.Company Net Margins Return on Equity Return on Assets Oncology Institute-17.63% -186.83% -34.58% CareDx -45.90%-53.70%-30.42% Does the media refer more to TOI or CDNA? In the previous week, CareDx had 19 more articles in the media than Oncology Institute. MarketBeat recorded 23 mentions for CareDx and 4 mentions for Oncology Institute. CareDx's average media sentiment score of 0.85 beat Oncology Institute's score of 0.42 indicating that CareDx is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Oncology Institute 0 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral CareDx 9 Very Positive mention(s) 1 Positive mention(s) 5 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Which has better valuation & earnings, TOI or CDNA? Oncology Institute has higher revenue and earnings than CareDx. Oncology Institute is trading at a lower price-to-earnings ratio than CareDx, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioOncology Institute$393.41M0.54-$83.07M-$0.71-3.94CareDx$346.42M2.48-$190.28M$1.1513.41 SummaryCareDx beats Oncology Institute on 11 of the 18 factors compared between the two stocks. Get Oncology Institute News Delivered to You Automatically Sign up to receive the latest news and ratings for TOI and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TOI vs. The Competition Export to ExcelMetricOncology InstituteOffices & clinics of medical doctors IndustryMedical SectorNASDAQ ExchangeMarket Cap$211.57M$1.62B$5.33B$7.99BDividend YieldN/AN/A5.45%4.20%P/E Ratio-3.5927.2722.6219.04Price / Sales0.541.41393.05108.07Price / CashN/A36.0138.4134.62Price / Book3.6413.446.634.32Net Income-$83.07M-$52.07M$3.23B$248.50M7 Day Performance5.66%8.66%-1.77%1.87%1 Year Performance201.08%49.31%15.45%5.28% Oncology Institute Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TOIOncology Institute0.5494 of 5 stars$2.80-4.1%N/A+201.1%$211.57M$393.41M-3.59660Upcoming EarningsCDNACareDx3.4686 of 5 stars$15.17+1.1%$30.33+100.0%+4.0%$844.68M$346.42M-5.62740Insider TradeAnalyst RevisionNews CoveragePositive NewsGap DownFLGTFulgent Genetics3.3522 of 5 stars$19.56-4.8%$20.50+4.8%-10.1%$603.74M$283.47M-3.541,010Gap DownHigh Trading VolumeCSTLCastle Biosciences2.6082 of 5 stars$18.75-3.1%$38.75+106.7%-30.7%$540.84M$332.07M93.75540Earnings ReportFTREFortrea3.4968 of 5 stars$5.93-5.3%$15.82+166.7%-81.4%$536.90M$2.70B-1.7318,000Upcoming EarningsNews CoverageTALKTalkspace3.7677 of 5 stars$3.13-1.9%$4.50+43.8%+7.5%$527.21M$187.59M313.31500Analyst RevisionAUNAAuna4.0083 of 5 stars$6.97+0.7%$13.50+93.8%-27.6%$515.20M$4.39B18.3314,958CELCCelcuity2.4907 of 5 stars$10.85-0.5%$30.17+178.0%-39.7%$410.55MN/A-4.1640Upcoming EarningsPositive NewsEHABEnhabit1.6312 of 5 stars$7.98-0.9%$8.50+6.5%+22.9%$404.03M$1.03B-3.4410,900Earnings ReportNews CoveragePositive NewsGap UpINNVInnovAge1.0641 of 5 stars$2.89-8.3%$5.00+73.0%-11.5%$390.86M$806.61M-15.212,000Earnings ReportAnalyst RevisionPSNLPersonalis3.7561 of 5 stars$4.26+2.4%$7.80+83.1%+221.0%$376.19M$84.61M-2.54400Earnings ReportAnalyst Revision Related Companies and Tools Related Companies CareDx Alternatives Fulgent Genetics Alternatives Castle Biosciences Alternatives Fortrea Alternatives Talkspace Alternatives Auna Alternatives Celcuity Alternatives Enhabit Alternatives InnovAge Alternatives Personalis Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:TOI) was last updated on 5/12/2025 by MarketBeat.com Staff From Our PartnersThis next market event could mean total financial ruin for someYou think the volatility is over? Think again … Because it’s just getting started. In fact, according...Weiss Ratings | SponsoredThink NVDA’s run was epic? You ain’t seen nothin’ yetAsk most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, ...Timothy Sykes | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredThe Man I Turn to In Times Like ThisA storm is brewing in the markets: new tariffs, recession warnings, and panic in the headlines. That’s when pu...Stansberry Research | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredThe one deadline Elon can't afford to miss...For years, Elon Musk made headlines for blowing past deadlines — so often that investors coined a nickname for...Brownstone Research | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding The Oncology Institute, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Oncology Institute With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy TOI Stock Free TOI Stock Alerts